Takeda Pharmaceutical Company Limited announced that at its ordinary general meeting of shareholders held on June 29, 2022 shareholders elected John Maraganore as director. Yoshiaki Fujimori and Kimberly A. Reed were newly elected to Audit and Supervisory Committee Members assumed their respective offices.